-
SA set for long wait for COVID-19 vaccine as roll out takes shape
Countries like the United States will ensure its citizens are catered to first, while the rest of us will have to wait a little longer to be protected from the coronavirus, which has infected more than 55 million people around the world and claimed the lives of more than 1.3 million others.
-
SA COVID-19 resurgence no surprise for Prof Mahdi, says citizens complacent
Scientists have noticed that complacency and super spreader events are some of the key drivers in the second wave gripping Europe, which is once again the epicentre of the coronavirus pandemic and they're calling on South Africans to learn from Europe's mistakes.
-
SA can learn from Europe's COVID-19 second wave, say experts
Several countries have gone into yet another lockdown to stop the spread of the virus like in Austria, Belgium, Germany, France, Italy and Spain, many of which have fewer coronavirus cases than South Africa at the moment.
-
New COVID-19 survey launched to determine extent of infections in Gauteng
One of the country’s top scientists, Professor Shabir Madhi on Friday said they started on Monday by visiting households in the province to determine how widespread the virus is.
-
Public hospitals take breather as COVID-19 infections slow but ready for surge
With experts sounding the alarm on a possible second spike in coronavirus transmissions, public hospitals are confident they’ll be better prepared.
-
Are South Africans becoming immune to COVID-19?
Professor of Vaccinology at Wits University, Shabir Madhi, said that some sectors of the population could have developed immune cells.
-
SA ready to move to level 1 lockdown, but must do so cautiously – Prof Madhi
Wits Professor Shabir Madhi, who is in charge of the South African leg of the Oxford COVID-19 vaccine trial, has called for the re-opening of borders and resumption of international flights.
-
Halting COVID-19 trial shows good oversight, says Wits' Prof Madhi
As part of regulatory procedure, further vaccination of participants enrolled in the study has been halted after a volunteer in the UK fell ill.
-
SA needs to explore different COVID-19 vacine options, says Wits specialist
Wits University has this week started screening participants for its second vaccine efficacy trial.
-
Wits University begins SA’s first COVID-19 vaccine trial
The institution said 2,000 people between the ages of 18 and 65 would be enrolled for the trial, which was expected to be run at multiple sites in South Africa.
-
[LISTEN] Wits researchers pioneer vaccine to prevent stillbirths, infant deaths
Professor of vaccinology at Wits University Shabir Madhi says pregnant women are prone to the streptococcus bacteria, which is what results in stillbirths and infant deaths.
